Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
SLGL Stock Forecast 2025-2026
$0.78
Current Price
$21.79M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to SLGL Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
SLGL Price Momentum
+34.5%
1 Week Change
+41.8%
1 Month Change
-12.4%
1 Year Change
-16.1%
Year-to-Date Change
-52.6%
From 52W High of $1.65
+134.1%
From 52W Low of $0.33
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Sol-Gel (SLGL) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on SLGL and similar high-potential opportunities.
Latest SLGL Stock Price Targets & Analyst Predictions
SLGL has shown a year-to-date change of -16.1% and a 1-year change of -12.4%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for SLGL. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SLGL Analyst Ratings
1
Buy
0
Hold
0
Sell
SLGL Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.78
Latest SLGL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SLGL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 19, 2024 | Raymond James | Elliot Wilbur | Outperform | Downgrade | $4.00 |
| May 22, 2024 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Reiterates | $6.00 |
| May 20, 2024 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $6.00 |
| Nov 13, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $9.00 |
| Aug 14, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $12.00 |
| Aug 11, 2023 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $7.00 |
| Jul 24, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Reiterates | $19.00 |
| Jul 19, 2023 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $9.00 |
| Jun 5, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Reiterates | $19.00 |
| Apr 12, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Reiterates | $19.00 |
| Mar 14, 2023 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $10.00 |
| Feb 1, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Reiterates | $19.00 |
| Nov 14, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $19.00 |
| Nov 11, 2022 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $13.00 |
| Oct 21, 2022 | Jefferies | Glen Santangelo | Hold | Initiates | $5.50 |
| Aug 29, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $22.00 |
| May 16, 2022 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $16.00 |
| Apr 25, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $21.00 |
| Apr 1, 2022 | Raymond James | Elliot Wilbur | Strong Buy | Maintains | $17.00 |
| Nov 15, 2021 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $20.00 |
Sol-Gel Technologies Ltd. (SLGL) Competitors
The following stocks are similar to Sol-Gel based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Sol-Gel Technologies Ltd. (SLGL) Financial Data
Sol-Gel Technologies Ltd. has a market capitalization of $21.79M with a P/E ratio of -0.8x. The company generates $11.71M in trailing twelve-month revenue with a -81.7% profit margin.
Revenue growth is +2,416.9% quarter-over-quarter, while maintaining an operating margin of -15.4% and return on equity of -24.6%.
Valuation Metrics
Market Cap
$21.79M
Enterprise Value
$-4,954,574
P/E Ratio
-0.8x
PEG Ratio
-1.6x
Price/Sales
1.9x
Growth & Margins
Revenue Growth (YoY)
+2,416.9%
Gross Margin
N/A
Operating Margin
-15.4%
Net Margin
-81.7%
EPS Growth
+2,416.9%
Financial Health
Cash/Price Ratio
+128.8%
Current Ratio
5.8x
Debt/Equity
3.8x
ROE
-24.6%
ROA
-15.2%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Sol-Gel Technologies Ltd. (SLGL) Business Model
About Sol-Gel Technologies Ltd.
What They Do
Develops dermatological treatments using nanotechnology.
Business Model
Sol-Gel Technologies generates revenue by developing and commercializing topical dermatology products aimed at common skin conditions like acne and rosacea. Their proprietary aerosol-based drug delivery platform enhances the effectiveness and stability of treatments, attracting partnerships and collaborations to expand their product offerings.
Additional Information
Founded in 1997 and headquartered in Israel, Sol-Gel is committed to research and development, focusing on innovative solutions in the dermatology sector. Their technology leverages microencapsulation systems to improve patient experiences, positioning them favorably in the competitive pharmaceutical market.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
36
CEO
Mr. Moshe Arkin
Country
Israel
IPO Year
2007
Website
www.sol-gel.comSol-Gel Technologies Ltd. (SLGL) Latest News & Analysis
Latest News
Quick Summary
Sol-Gel Technologies will receive $16 million in 2025, extending its cash runway into Q1 2027. It expects Phase III trial results for SGT-610 by Q4 2026, with a U.S. market potential of $400-$500 million.
Why It Matters
Sol-Gel's $16 million funding extends its cash runway, supporting key clinical trials. Positive results could unlock a $500 million market opportunity, enhancing investor confidence and potential returns.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
A market intelligence report highlights key technologies, competition, and opportunities in the global surface engineering industry, projecting trends and developments through 2035.
Why It Matters
Insights into innovative technologies and market dynamics in the surface engineering industry can guide investment decisions, highlighting growth areas and competitive advantages for potential returns.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Sol-Gel's Q4 2024 earnings are expected to benefit from increased licensing revenues from partnerships.
Why It Matters
Increased licensing revenues can signal strong partnerships and revenue growth potential, positively influencing Sol-Gel's stock performance and investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks utilizes its Zacks Rank system, focusing on earnings estimates and revisions, to identify strong stocks while monitoring value, growth, and momentum trends.
Why It Matters
The emphasis on earnings estimates and revisions indicates potential stock performance, guiding investors to identify promising opportunities in varying market conditions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
SolGel Technologies (SLGL) has received a Zacks Rank #2 (Buy) upgrade, indicating growing optimism about its earnings prospects.
Why It Matters
SolGel Technologies' upgrade to a Zacks Rank #2 signals strong earnings potential, indicating positive market sentiment and possible stock price appreciation.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Sol-Gel Technologies appointed Mori Arkin as interim CEO starting January 1, 2025. The company is conducting Phase 3 trials for SGT-610 in Gorlin Syndrome and ongoing studies for SGT-210 in Darier disease.
Why It Matters
Mori Arkin's interim CEO role may influence strategic direction. Ongoing clinical trials for SGT-610 and SGT-210 highlight potential growth and market expansion for Sol-Gel Technologies.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About SLGL Stock
What is Sol-Gel Technologies Ltd.'s (SLGL) stock forecast for 2025?
Analyst forecasts for Sol-Gel Technologies Ltd. (SLGL) are not currently available. The stock is trading at $0.78.
Is SLGL stock a good investment in 2025?
According to current analyst ratings, SLGL has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.78. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SLGL stock?
Price predictions from Wall Street analysts for SLGL are not currently available. The stock is trading at $0.78.
What is Sol-Gel Technologies Ltd.'s business model?
Sol-Gel Technologies generates revenue by developing and commercializing topical dermatology products aimed at common skin conditions like acne and rosacea. Their proprietary aerosol-based drug delivery platform enhances the effectiveness and stability of treatments, attracting partnerships and collaborations to expand their product offerings.
What is the highest forecasted price for SLGL Sol-Gel Technologies Ltd.?
Price targets from Wall Street analysts for SLGL are not currently available. The stock is trading at $0.78.
What is the lowest forecasted price for SLGL Sol-Gel Technologies Ltd.?
Price targets from Wall Street analysts for SLGL are not currently available. The stock is trading at $0.78.
What is the overall SLGL consensus from analysts for Sol-Gel Technologies Ltd.?
The overall analyst consensus for SLGL is bullish. Out of 4 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell.
How accurate are SLGL stock price projections?
Stock price projections, including those for Sol-Gel Technologies Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 28, 2025 6:15 AM UTC